IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $177,405 | -7.2% | 38,990 | +43.6% | 0.00% | 0.0% |
Q2 2023 | $191,206 | +112.0% | 27,160 | +84.0% | 0.00% | – |
Q1 2023 | $90,190 | -4.4% | 14,761 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $94,323 | -33.1% | 14,761 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $141,000 | -13.5% | 14,761 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $163,000 | -46.4% | 14,761 | -19.1% | 0.00% | 0.0% |
Q1 2022 | $304,000 | -17.8% | 18,247 | -6.0% | 0.00% | -50.0% |
Q4 2021 | $370,000 | +13.8% | 19,408 | +47.1% | 0.00% | 0.0% |
Q3 2021 | $325,000 | -5.2% | 13,191 | -0.0% | 0.00% | 0.0% |
Q2 2021 | $343,000 | -17.5% | 13,197 | +0.5% | 0.00% | 0.0% |
Q1 2021 | $416,000 | -35.4% | 13,136 | -5.4% | 0.00% | -50.0% |
Q4 2020 | $644,000 | +63.5% | 13,883 | +16.1% | 0.00% | +33.3% |
Q3 2020 | $394,000 | +30.9% | 11,959 | +9.1% | 0.00% | 0.0% |
Q2 2020 | $301,000 | +8.3% | 10,957 | +18.0% | 0.00% | 0.0% |
Q1 2020 | $278,000 | +26.4% | 9,285 | +16.7% | 0.00% | +50.0% |
Q4 2019 | $220,000 | +30.2% | 7,953 | -14.6% | 0.00% | +100.0% |
Q3 2019 | $169,000 | -25.9% | 9,313 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $228,000 | +88.4% | 9,313 | -26.8% | 0.00% | +100.0% |
Q1 2019 | $121,000 | +7.1% | 12,718 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $113,000 | -28.0% | 12,718 | -8.6% | 0.00% | 0.0% |
Q3 2018 | $157,000 | -11.8% | 13,918 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $178,000 | +22.8% | 13,918 | +61.8% | 0.00% | +100.0% |
Q1 2018 | $145,000 | – | 8,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |